Having an efficient and scalable manufacturing production process of Adeno-Associated Virus (AAV) vectors remains one of the most challenging problems in the industry for meeting the high demand of AAV for clinical application in gene therapy. The current production process of AAV relies on the co-transfection of three plasmids containing the main virus structural and […]
Read More